Wear
A comfortable wearable accessory you put on and forget. No cuff, no clinic, no appointment — it complements the watch and phone you already own.
Investors & partners
Investors & partners
Inside your arteries, cardiovascular disease builds silently for years — usually caught only after a heart attack or stroke. As CardioVAI engages, the uncertainty clears — surfacing the early signs of arterial change, long before symptoms appear.
A comfortable, non-invasive wearable accessory that continuously senses early signs of arterial change — turning them into clear cardiovascular insight on one live dashboard that follows the patient in real time.
A comfortable wearable accessory you put on and forget. No cuff, no clinic, no appointment — it complements the watch and phone you already own.
CardioVAI reads the body continuously and turns it into clear, real-time insight — privately, effortlessly, all day long.
The dashboard turns the incoming streams into a living picture — flow, pressure, oxygen, stress — and flags vascular risk before symptoms appear.
FIG. 01 — CONTINUOUS SENSING TURNS INTO ONE LIVE CARDIOVASCULAR PICTURE · EVERY READING UPDATES THE PATIENT'S STATE IN REAL TIME
The same stream that feeds the dashboard mirrors to the patient's phone, beat for beat — waveforms, vitals and alerts, wherever they are.
CardioVAI's AI turns continuous signals into live insight in real time — designed around privacy, and built to scale from one person to one million without borders.
FIG. 02 — GLOBAL REACH · EVERY LINE IS A LIVE, PRIVATE CONNECTION TO THE CARDIOVAI AI CORE
Clinical screening is episodic, bulky and expensive. Smartwatches track heart rate and rhythm — but can't assess the health of the arteries themselves. CardioVAI closes that gap.
Insight that today requires a clinic — available 24/7, effortlessly, from a comfortable wearable you barely notice.
An accessory that fits the wearable ecosystem you already own — working alongside your watch and phone, not replacing them.
Catches early signs of arterial change long before symptoms appear — turning silent cardiovascular risk into a clear, preventative signal.
US provisional patent filed, and a wellness-support positioning for a faster, lighter regulatory path to market.
Cardiovascular disease is the world's #1 cause of death — and consumer-grade early detection of arterial change barely exists yet.
Cardiovascular deaths every year worldwide — the #1 cause of death globally.
Global wearable medical device market, 2024 → 2030 (~25% CAGR).
Consumer-grade early detection of arterial stiffness & sub-clinical disease — a wide-open gap.
Sources: World Health Organization (WHO), CVD fact sheet 2022 · Grand View Research / MarketsandMarkets, 2024–2030.
CardioVAI is at pre-seed / proof-of-concept stage, with a validated lab prototype and a US provisional patent filed. We're inviting strategic investors, clinical research collaborators, and commercial partners to help bring preventative cardiovascular intelligence into everyday life.
One click opens a ready-to-send email straight to our founder.